This excerpt taken from the TPTX 8-K filed Nov 12, 2008.
Member of the Board of Directors
LA JOLLA, CA, November 12, 2008 TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that the Board of Directors has appointed Evelyn Graham as the Companys Chief Executive Officer and as a member of the Companys Board of Directors. Ms. Graham had been serving as the Companys acting Chief Executive Officer since September 1, 2008.
Ev has done an impressive job as acting CEO in managing the transition of our company and building a platform for the future, said Peter Davis, Chairman of the TorreyPines Board of Directors. We are delighted that she has agreed to become CEO and a member of the Board at a time when TorreyPines is completing important clinical trials that hold promise for the companys future. With her considerable drug development experience as well as global senior management roles, she has the right mix of skills and experience to successfully lead the Company in meeting its strategic objectives.
I am excited by this opportunity and look forward to continuing to work with TorreyPines talented management team and dedicated employees, said Ms. Graham.
Ms. Graham joined TorreyPines in 2004 as Vice President, Development. She was then promoted to Vice President, Corporate Development in 2005, Chief Operating Officer in 2006 and acting Chief Executive Officer in September 2008. Prior to joining TorreyPines Ms. Graham was Executive Director, Development Operations at Purdue Pharma from 2000 to 2003. From 1998 to 2000, she was Senior Vice President of Business Development at Ingenix Pharmaceutical Services, a division of UHG, and served as Vice President of Clinical Operations at Worldwide Clinical Trials, prior to its acquisition by UHG. Previously, Ms. Graham held positions in operations management, healthcare utilization and organizational planning at Bayer Corporation and Wyeth Pharmaceuticals (formerly Ayerst Laboratories). Ms. Graham holds a B.A. in biology from the University of Delaware and an M.B.A. from the University of Connecticut.